Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANGO
ANGO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANGO News
Analysis of Strong and Weak Stocks Ahead of Earnings Reports
1d ago
seekingalpha
AngioDynamics to Report Q3 FY2026 Financial Results
Mar 19 2026
Newsfilter
Bastion Asset Management Acquires Stake in Parsons
Feb 27 2026
Fool
Bastion Asset Management Acquires $8M Stake in Parsons
Feb 27 2026
Yahoo Finance
AngioDynamics to Present at Global Healthcare Conference
Feb 23 2026
Newsfilter
NanoKnife Technology Expands European Indications for Tumor Treatment
Feb 19 2026
Newsfilter
AngioDynamics (ANGO) Q3 2025 Earnings Transcript
Jan 06 2026
NASDAQ.COM
AngioDynamics (ANGO) Q1 2026 Earnings Transcript
Jan 06 2026
NASDAQ.COM
AngioDynamics (ANGO) Q2 2026 Earnings Transcript
Jan 06 2026
NASDAQ.COM
AngioDynamics (ANGO) Q1 2025 Earnings Transcript
Jan 06 2026
NASDAQ.COM
Alumis Inc. Shares Surge 132% After Successful Phase 3 Trial Results
Jan 06 2026
Benzinga
AngioDynamics Reports 8.8% Revenue Growth in Q3 but Shares Plunge 13.1%
Jan 06 2026
Fool
AngioDynamics Surpasses Expectations with $79.4M Sales and Break-Even EPS
Jan 06 2026
Benzinga
AngioDynamics Maintains 2026 Adjusted Loss Guidance, Raises Sales Outlook to $312M-$314M
Jan 06 2026
NASDAQ.COM
AngioDynamics Reports 8.8% Net Sales Growth to $79.4 Million in Q2
Jan 06 2026
Newsfilter
Microchip Technology Raises Q3 FY2026 Sales Guidance to $1.185 Billion
Jan 06 2026
Benzinga
Show More News
